KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Operating Expenses (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Operating Expenses for 17 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 16.04% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.5 billion through Dec 2025, up 4.63% year-over-year, with the annual reading at $8.5 billion for FY2025, 4.63% up from the prior year.
  • Operating Expenses hit $2.3 billion in Q4 2025 for Bausch Health Companies, up from $2.1 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.4 billion in Q4 2022 to a low of $1.5 billion in Q3 2021.
  • Historically, Operating Expenses has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2024.
  • Biggest five-year swings in Operating Expenses: skyrocketed 40.15% in 2021 and later dropped 27.36% in 2022.
  • Year by year, Operating Expenses stood at $1.8 billion in 2021, then soared by 32.8% to $2.4 billion in 2022, then decreased by 15.77% to $2.0 billion in 2023, then fell by 2.2% to $2.0 billion in 2024, then grew by 16.04% to $2.3 billion in 2025.
  • Business Quant data shows Operating Expenses for BHC at $2.3 billion in Q4 2025, $2.1 billion in Q3 2025, and $2.1 billion in Q2 2025.